Evaluation of serum platelet-derived growth factor receptor-ß and brain-derived neurotrophic factor levels in microvascular angina. [PDF]
Aslan G +5 more
europepmc +1 more source
Retraction notice to Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance: J Am Coll Cardiol 71 (2018) 969-979. [PDF]
Liu A +9 more
europepmc +1 more source
'Primary' Microvascular Angina: Clinical Characteristics, Pathogenesis and Management. [PDF]
Lanza GA, De Vita A, Kaski JC.
europepmc +1 more source
Increased levels of angiogenic factors in microvascular angina. [PDF]
Asl ER +6 more
europepmc +1 more source
Echocardiographic measurement of epicardial adipose tissue thickness in patients with microvascular angina. [PDF]
Kalçık M +8 more
europepmc +1 more source
International standardization of diagnostic criteria for microvascular angina
Standardization of diagnostic criteria for ischemic symptoms due to coronary microvascular dysfunction (CMD) is needed for further investigation of patients presenting with anginal chest pain consistent with “microvascular angina” (MVA).
Paolo G Camici
exaly +3 more sources
Related searches:
Ranolazine for Symptomatic Management of Microvascular Angina.
American Journal of Therapeutics, 2020BACKGROUND Ranolazine is approved in the United States and Europe for chronic stable angina. Microvascular angina (MVA) is defined as angina with no obstructive coronary artery disease.
E. Rayner‐Hartley +5 more
semanticscholar +3 more sources
Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification
Current Cardiology Reports, 2020Matthieu Pelletier-Galarneau
exaly +2 more sources
Microvascular angina is a rather widely spread disease which is associated with high rate of unfavorable outcomes and substantial economical cost of examination and treatment. However problems of noninvasive diagnostics of the disease have not been entirely solved as well as clear-cut algorithm of management has not been elaborated.
A O, Iusupova +3 more
openaire +2 more sources

